Agenus Inc. (Nasdaq: AGEN), a leader in immuno‑oncology, today announced its investigational combination botensilimab plus balstilimab (BOT/BAL) is now available to eligible patients with refractory ...

We do not generally accept travel or accommodations (e.g., flights, hotel rooms, rental cars) from companies that we cover. In the event that we do, we will disclose the circumstances in any resulting ...

Abstract: This research paper explores the design and implementation of an event-driven monitoring system for Wi-Fi6 Access Points (APs) using Java-based microservices architecture. WiFi 6's primary ...

Once the ANSM authorizes AAC, hospital use is covered 100% by Assurance Maladie. Hospitals are reimbursed at the invoiced purchase price (TTC), outside the Diagnosis-related Group (DRG), referred to ...